别嘌醇相关严重皮肤不良反应的种族/民族差异及危险因素:一项队列研究
该研究利用美国医疗补助计划数据识别1999至2012年间别嘌醇初始使用者,分析种族/民族及疑似危险因素与住院别嘌醇相关严重皮肤不良反应(AASCARs)的关联并计算相对风险。共400401例初始使用者中记录203例住院AASCARs,黑种人、亚裔及夏威夷原住民/太平洋岛民风险显著高于白种人或西班牙裔,年长女性高危种族者风险超过低危年轻男性12倍。
要点
- 黑种人、亚裔及夏威夷原住民/太平洋岛民的住院AASCARs风险分别为白种人或西班牙裔的3.00、3.03及6.68倍。
- 女性、年龄≥60岁、慢性肾脏病及初始别嘌醇剂量>100 mg/天与AASCARs风险独立相关。
- 高危种族年长女性(≥60岁)住院AASCARs风险为低危种族年轻男性的12.25倍。
核心结论
- 住院AASCARs总体罕见,但黑种人、亚裔及夏威夷原住民/太平洋岛民风险显著更高,年长女性尤为突出。
- 数据支持以低剂量(如≤100 mg/天)起始别嘌醇的做法。
研究设计与样本
- 利用美国医疗补助计划数据识别1999至2012年间别嘌醇初始使用者,分析种族/民族及疑似危险因素与住院AASCARs的关联并计算相对风险。
主要发现
- 400401例别嘌醇初始使用者中记录203例住院AASCARs,约每1972例初始使用者中1例。
- AASCARs平均住院9.6天,43例(21%)死亡。
- 黑种人、亚裔及夏威夷原住民/太平洋岛民相比白种人或西班牙裔的多变量校正RR分别为3.00(95% CI 2.18至4.14)、3.03(95% CI 1.72至5.34)及6.68(95% CI 4.37至10.22)。
- 女性、年龄≥60岁、慢性肾脏病及初始别嘌醇剂量>100 mg/天分别与AASCARs风险升高2.5倍、1.7倍、2.3倍及1.9倍独立相关。
- 高危种族年长女性(≥60岁)相比低危种族年轻男性的多变量校正RR为12.25(95% CI 6.46至23.25)。
临床怎么用
- 作者认为数据支持以低剂量(如≤100 mg/天)起始别嘌醇的做法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine associations of race/ethnicity and purported risk factors with hospitalised allopurinol-associated severe cutaneous adverse reactions (AASCARs). METHODS: We used US Medicaid data to identify incident allopurinol users between 1999 and 2012. We examined the risk of hospitalised AASCARs according to race/ethnicity and purported key risk factors and calculated relative risks (RR). RESULTS: Among 400 401 allopurinol initiators, we documented 203 hospitalised AASCAR cases (1 in 1972 initiators). The average AASCAR hospitalisation was 9.6 days and 43 individuals (21%) died. The multivariable-adjusted RRs for AASCARs among blacks, Asians and Native Hawaiians/Pacific Islanders compared with whites or Hispanics were 3.00 (95% CI 2.18 to 4.14), 3.03 (95% CI 1.72 to 5.34) and 6.68 (95% CI 4.37 to 10.22), respectively. Female sex, older age (≥60 years), chronic kidney disease and initial allopurinol dose (>100 mg/day) were independently associated with a 2.5-fold, 1.7-fold, 2.3-fold and 1.9-fold higher risk of AASCAR, respectively. In our combined demographic analysis, older women (≥60 years) of a high-risk race/ethnicity (blacks, Asians or Native Hawaiians/Pacific Islanders) had over a 12-fold higher risk of hospitalised AASCARs than younger men of a low-risk race/ethnicity (whites or Hispanics) (multivariable-adjusted RR, 12.25; 95% CI 6.46 to 23.25). CONCLUSIONS: This racially diverse (yet mostly white) cohort study indicates that the risk of hospitalised AASCAR is rare overall, although blacks, Asians and Native Hawaiians/Pacific-Islanders have a substantially higher risk of hospitalised AASCARs, particularly among older women. These data also support the practice of initiating allopurinol at a low dose (eg, ≤100 mg/day).
引用
- Keller SF, Lu N, Blumenthal KG, et al. Racial/ethnic variation and risk factors for allopurinol-associated severe cutaneous adverse reactions: a cohort study. Ann Rheum Dis. 2018. PMID: 29653927. doi:10.1136/annrheumdis-2017-212905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。